A pilot study: does obesity begin in the first year of life?

Susan M Ludington-Hoe1, Lisaann S Gittner, Harold S Haller

  • 1Case Western Reserve University, Cleveland, OH, USA.

Clinical Pediatrics
|March 30, 2013
PubMed

Insights

Infant growth patterns in the first year can predict childhood obesity. Identifying abnormal weight gain early allows for timely interventions to promote healthy development and prevent future health issues.

Area of Science:

  • Pediatric endocrinology
  • Growth and development studies
  • Obesity research

Background:

  • Childhood obesity is a growing public health concern.
  • Early identification of obesity risk factors is crucial for effective intervention.
  • Understanding infant growth trajectories may offer insights into later obesity development.

Purpose of the Study:

  • To investigate the association between infant body mass index (BMI) growth patterns from birth to 1 year and the development of obesity at age 5 years.
  • To determine if early growth patterns can serve as predictive markers for childhood obesity.

Main Methods:

  • Longitudinal analysis of BMI growth patterns in healthy infants from birth to 1 year.
  • Children were categorized at age 5 years into normal weight, overweight, obese, and morbidly obese groups.
  • Statistical analysis of BMI means based on age postbirth.

Main Results:

  • Significant distinctions in infant BMI growth patterns were observed before 1 year of age.
  • Infants who were normal weight at 5 years exhibited a different growth trajectory in the first year compared to those who became overweight or obese.
  • Early growth patterns identified at less than 1 year predicted later weight status at 5 years.

Conclusions:

  • Obesity-related growth patterns are detectable in infancy.
  • Early identification of abnormal infant growth trajectories is clinically significant.
  • Interventions during the first year of life, guided by growth pattern analysis, can address precursors to later obesity and improve long-term health outcomes.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...